BioSpace News Archive

Biotech Bay

Revance Earns Great Place to Work® Certification for Second Year

Revance Therapeutics, Inc. announced the company is certified as a great workplace by the independent analysts at Great Place to Work® for the second consecutive year.

October 2, 2019
·
5 min read
Drug Development

Janssen Submits Supplemental New Drug Application to U.S. FDA for SPRAVATO® (esketamine) CIII Nasal Spray for the Rapid Reduction of Depressive Symptoms in Adults with Major Depressive Disorder Who Have Active Suicidal Ideation with Intent

If approved, SPRAVATO® would be the first treatment for this severely ill population(1) who historically have been excluded from antidepressant clinical trials

October 2, 2019
·
19 min read
Pharm Country

The Rogosin Institute Launches Important Kidney Health Screening Program in New York City

The Rogosin Institute announced the launch of a new Kidney Health Screening program.

October 2, 2019
·
3 min read
Drug Development

FDA Approves Labeling Supplement for Puma Biotechnology’s NERLYNX® (neratinib) for the Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

Interim data from the Phase II CONTROL Trial showed that the addition of prophylactic treatment with loperamide plus budesonide reduced the rate of discontinuation due to neratinib-associated diarrhea to 11% versus a discontinuation rate of 18% with loperamide alone.

October 2, 2019
·
7 min read
Business

Diplomat Announces Promotion of David Skomo to Chief Operating Officer of CastiaRx

Following the retirement of Chris Luthin, David Skomo Appointed COO at CastiaRx.

October 2, 2019
·
4 min read
Endo to Announce Third-Quarter 2019 Financial Results

Results on November 5, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a.m. ET before the U.S. financial markets open.

October 2, 2019
·
1 min read
Business

Elevate Health Sciences Receives one of Industry’s Most Rigorous Certifications from the Therapeutic Goods Administration (TGA) in Australia

The TGA is considered one of the most stringent regulatory agencies in the world and TGA certification represents meeting the agency’s high standards for manufacturing therapeutic goods, including nutritional supplements.

October 2, 2019
·
2 min read
Policy

MGI Sues Illumina Again for Patent Infringement in the United States

Complete Genomics, a U.S. affiliate of MGI, has filed a patent infringement counterclaim against Illumina in U.S. District Court for the Northern District of California.

October 2, 2019
·
2 min read
Business

Entos Pharmaceuticals Announces Research, Development and Collaboration Agreement

Entos Pharmaceuticals Inc. announced it has entered into a research, development and collaboration agreement with a clinical stage biopharmaceutical company focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.

October 2, 2019
·
2 min read
EMGALITY™ (galcanezumab) now available in Canada for preventive treatment of migraine

New anti-CGRP treatment for the prevention of migraine in adults with at least 4 migraine days per month

October 2, 2019
·
6 min read